Orphan Australia launches Gelclair® in Australia for the management of oral mucositis more....

Guilford Announces Marketing And Distribution Agreement For Gliadel® Implants In Australia And New Zealand more...

16 May 2002

SALOFALK® (mesalazine) oral granules and enemas approved for marketing in Australia more...

20 June 2001

FERRIPROX™ receives Orphan Drug designation in Australia more...

14 June, 2001

REMODULIN^TM receives Orphan Drug designation in Australia more...

12 June, 2001

Cephalon Announces Marketing and Distribution Agreement For ACTIQ® (oral transmucosal fentanyl citrate) in Australia and New Zealand more...

28 February 2001

Kidney stones can now be treated by specialists with new medication
- UROCIT®-K (potassium citrate) tablets are now available more...

3 January, 2001

United Therapeutics and Orphan Australia sign UT-15 Distribution Agreement more...

October 2000

Ursofalk® (ursodeoxycholic acid) available on PBS for Primary Biliary Cirrhosis
from November 1st 2000 more...

31 January 2000

First anti-craving drug to treat alcohol dependence available on PBS
-ReVia® (naltrexone HCI) PBS listed 1 February 2000 more...

11 December 1999

ReVia (Naltrexone) wins PBS listing - but only for alcohol addiction more...

28 February 1999

Naltrexone (REVIA) now available in Australia for treatment of alcohol dependence more...

4 February 1999

ReVia (naltrexone) licensed for treatment of alcohol dependence more...

4 February 1999

New drug therapy to aid specialists and GPs in the treatment of Alcohol Dependence more...